Cockayne Syndrome: Clinical Aspects

  • Masaya KubotaEmail author


Cockayne syndrome (CS) is a rare autosomal recessive degenerative disorder caused by deficient nucleotide excision repair. It is characterized by a distinctive facial appearance (sunken eyes and cheeks); postnatal poor growth; and progressive multisystem dysfunction, including of the central and peripheral nervous systems. Many clinical assessments are required to support a diagnosis of CS, and comprehensive investigations of the needs of patients and their families are also necessary. Although renal failure is not included in the diagnostic criteria for CS, it is considered to be an important symptom that can affect survival. Genetic heterogeneity in the renal pathology of CS might also exist. Clinicians should coordinate with various specialists to ensure appropriate managements. This approach will ensure that pediatric CS patients and their families will be able to spend meaningful time together while the patient retains a good quality of life.


  1. 1.
    Cockayne EA. Dwarfism with retinal atrophy and deafness. Arch Dis Child. 1936;11:1–8.CrossRefGoogle Scholar
  2. 2.
    Cockayne EA. Dwarfism with retinal atrophy and deafness. Arch Dis Child. 1946;21:52–4.CrossRefGoogle Scholar
  3. 3.
    Sugarman GI, Landing BH, Reed WB. Cockayne syndrome: clinical study of two patients and neuropathologic findings in one. Clin Pediatr. 1977;16:225–32.CrossRefGoogle Scholar
  4. 4.
    Nance MA, Berry SA. Cockayne syndrome: review of 140 cases. Am J Med Genet. 1992;42:68–84.CrossRefGoogle Scholar
  5. 5.
    Natale V. A comprehensive description of the severity groups in Cockayne syndrome. Am J Med Genet A. 2011;155A:1081–95.CrossRefGoogle Scholar
  6. 6.
    Kubota M, Ohta S, Ando A, Koyama A, Terashima H, Kashii H, Hoshino H, Sugita K, Hayashi M. Nationwide survey of Cockayne syndrome in Japan: incidence, clinical course and prognosis. Pediatr Int. 2015;57:339–47.CrossRefGoogle Scholar
  7. 7.
    Wilson BT, Stark Z, Sutton RE, Danda S, Ekbote AV, Elsayed SM, Gibson L, Goodship JA, Jackson AP, Keng WT, King MD, McCann E, Motojima T, Murray JE, Omata T, Pilz D, Pope K, Sugita K, White SM, Wilson IJ. The Cockayne syndrome natural history (CoSyNH) study: clinical findings in 102 individuals and recommendations for care. Genet Med. 2016;18:483–93.CrossRefGoogle Scholar
  8. 8.
    Laugel V. Cockayne syndrome: the expanding clinical and mutational spectrum. Mech Ageing Dev. 2013;134:161–70.CrossRefGoogle Scholar
  9. 9.
    Rapin I, Weidenheim K, Lindenbaum Y, Rosenbaum P, Merchant SN, Krishna S, Dickson DW. Cockayne syndrome in adults: review with clinical and pathologic study of a new case. J Child Neurol. 2006;21:991–1006.CrossRefGoogle Scholar
  10. 10.
    Hayashi M, Miwa-Saito N, Tanuma N, Kubota M. Brain vascular changes in Cockayne syndrome. Neuropathology. 2012;32:113–7.CrossRefGoogle Scholar
  11. 11.
    Scheibye-Knudsen M, Ramamoorthy M, Sykora P, Maynard S, Lin PC, Minor RK, Wilson DM 3rd, Cooper M, Spencer R, de Cabo R, Croteau DL, Bohr VA. Cockayne syndrome group B protein prevents the accumulation of damaged mitochondria by promoting mitochondrial autophagy. J Exp Med. 2012;209:855–69.CrossRefGoogle Scholar
  12. 12.
    Kleijer WJ, et al. Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. DNA Repair (Amst). 2008;7:744–50.CrossRefGoogle Scholar
  13. 13.
    Morris DP, Alian W, Maessen H, Creaser C, Demmons-O’Brien S, Van Wijhe R, Bance M. Cochlear implantation in Cockayne syndrome: our experience of two cases with different outcomes. Laryngoscope. 2007;117:939–43.CrossRefGoogle Scholar
  14. 14.
    Cook S. Cockayne’s syndrome. Another cause of difficult intubation. Anaesthesia. 1982;37:1104–7.CrossRefGoogle Scholar
  15. 15.
    Meira LB, Graham JM Jr, Greenberg CR, Busch DB, Doughty AT, Ziffer DW, Coleman DM, Savre-Train I, Friedberg EC. Manitoba aboriginal kindred with original cerebro-oculo- facio-skeletal syndrome has a mutation in the Cockayne syndrome group B (CSB) gene. Am J Hum Genet. 2000;66:1221–8.CrossRefGoogle Scholar
  16. 16.
    Nakazawa Y, Sasaki K, Mitsutake N, Matsuse M, Shimada M, Nardo T, Takahashi Y, Ohyama K, Ito K, Mishima H, Nomura M, Kinoshita A, Ono S, Takenaka K, Masuyama R, Kudo T, Slor H, Utani A, Tateishi S, Yamashita S, Stefanini M, Lehmann AR, Yoshiura K, Ogi T. Mutations in UVSSA cause UV-sensitive syndrome and impair RNA polymerase IIo processing in transcription-coupled nucleotide-excision repair. Nat Genet. 2012;44:586–92.CrossRefGoogle Scholar
  17. 17.
    Iwasaki S, Kaga K. Chronological changes of auditory brainstem responses in Cockayne’s syndrome. Int J Pediatr Otorhinolaryngol. 1994;30:211–21.CrossRefGoogle Scholar
  18. 18.
    Scaioli V, D’Arrigo S, Pantaleoni C. Unusual neurophysiological features in Cockayne’s syndrome: a report of two cases as a contribution to diagnosis and classification. Brain and Development. 2004;26(4):273–80.CrossRefGoogle Scholar
  19. 19.
    Koob M, Laugel V, Durand M, Fothergill H, Dalloz C, Sauvanaud F, Dollfus H, Namer IJ, Dietemann JL. Neuroimaging in Cockayne syndrome. AJNR Am J Neuroradiol. 2010;31:1623–30.CrossRefGoogle Scholar
  20. 20.
    Nakajima E, Hattori A, Ito T, Kobayashi S, Nakajima Y, Ando N, Sugita K, Saitoh S. Onset of complications and management of Cockayne syndrome type 1. J Jpn Pediatr Soc. 2013;117:760–5. (in Japanese).Google Scholar
  21. 21.
    Motojima T, Sugita K, Omata T, Fujii K. Clinical examination of renal function in Cockayne syndrome. No To Hattatsu. 2014;46:311–4. (in Japanese).PubMedGoogle Scholar
  22. 22.
    Zappitelli M, Parvex P, Joseph L, Paradis G, Grey V, Lau S, Bell L. Derivation and validation of cystatin C-based prediction equations for GFR in children. Am J Kidney Dis. 2006;48(2):221–30.CrossRefGoogle Scholar
  23. 23.
    Okoshi Y, Tanuma N, Miyata R, Hayashi M. Melatonin alterations and brain acetylcholine lesions in sleep disorders in Cockayne syndrome. Brain Dev. 2014;36:907–13.CrossRefGoogle Scholar
  24. 24.
    Neilan EG, et al. Response of motor complications in Cockayne syndrome to carbidopa-levodopa. Arch Neurol. 2008;65:1117–21.CrossRefGoogle Scholar
  25. 25.
    Hebb MO, Gaudet P, Mendez I. Deep brain stimulation to treat hyperkinetic symptoms of Cockayne syndrome. Mov Disord. 2006;21:112–5.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Division of NeurologyNational Center for Child Health and DevelopmentTokyoJapan

Personalised recommendations